Phase Genomics, a US-based biotech spinout of University of Washington, has raised $1m from Washington Research Foundation, which invests in companies linked to universities in the US state, and Congruent Ventures, Geekwire reported on Sunday.
Founded in 2015, Phase Genomics was the first spinout to emerge out of the Genome Sciences department at the university. The company has created technology to identify individual micro-organisms and viruses and figure out which of them are commingling inside cells.
The spinout was co-founded…
